| 3β-HSD | 3β hydroxysteroid dehydrogenase |
| 4E-BP1 | Eukaryotic translation initiation factor 4E binding protein 1 |
| ADT | Androgen deprivation therapy |
| AD | Androstenedione |
| AGC | cAMP-dependent, cGMP-dependent and protein kinase C |
| AKTi | AKT inhibitor |
| AMP | Adenosine monophosphate |
| AMPK | 5′ AMP-activated protein kinase |
| APC | Adenomatous polyposis coli |
| AR | Androgen receptor |
| ARE | Androgen responsive element |
| ARF1 | Adenosine ribosylation factor 1 |
| ATG14 | Autophagy related 14 homolog |
| ATP | Adenosine triphosphate |
| AXIN | Axis inhibitor protein |
| BAD | Bcl-2-associated death promoter |
| BMK-1 | Big mitogen-activated protein kinase-1 |
| CaMKII | Calmodulin-dependent kinase 2 |
| CAMKKβ | Ca(2+)/calmodulin-dependent protein kinase kinase β |
| CAV1 | Caveolin-1 |
| CDK4 | Cyclin-dependent kinase 4 |
| c-JUN | Transcription factor AP-1 |
| CK1 | Casein kinase 1 |
| CAN | Copy number alteration |
| CREB | cAMP response element-binding protein |
| CRPC | Castrate resistant prostate cancer |
| CYP17A1 | Cytochrome P450 17A1 |
| DEPTOR | Dishevelled, EGL-10 and pleckstrin (DEP) domain-containing mTOR-interacting protein |
| DFCI | Dana-Farber Cancer Institute |
| DHEA | Dehydroepiandrosterone |
| DHTDVL | DihydrotestosteroneDisheveled |
| EIF4E | Eukaryotic translation initiation factor 4E |
| EGF | Epidermal growth factor |
| EGFR | Epidermal growth factor receptor |
| EGR1 | Early growth response 1 |
| EMT | Epithelial-to-mesenchymal transition |
| ERG1 | ETS-related Gene 1 |
| ERK1 | Mitogen-activated protein kinase 3 |
| ERK2 | Mitogen-activated protein kinase 1 |
| EZH2 | Enhancer of zeste homolog 2 |
| FKBP5 | FK506 binding protein 5 |
| FOXO | Forkhead box protein O |
| FGFR | Fibroblast growth factor receptor |
| FZD | Frizzled family receptor |
| GAB1 | GRB2-associated binder-1 |
| GDP | Guanosine diphosphate |
| GLUT3 | Glucose transporter 3 |
| GnRH | Gonadotrophin-releasing hormone |
| GPCR | G-protein coupled receptor |
| GR | Glucocorticoid receptor |
| GRB2 | Growth factor receptor-bound protein 2 |
| GRB10 | Growth factor binding protein 10 |
| GSK3β | Glycogen synthase kinase 3 beta |
| GTP | Guanosine triphosphate |
| HDAC3 | Histone deacetylase 3 |
| HER2/3 | Human epidermal growth factor receptor 2/3 |
| HSD3B/17B3 | Hydroxysteroid dehydrogenase 3B/17B3 |
| HSP70/90 | Heat shock protein 70/90 |
| IGF | Insulin growth factor |
| IGF-1 | Insulin growth factor 1 |
| IHC | Immunohistochemistry |
| IL6 | Interleukin 6 |
| INPP4B | Inositol polyphosphate 4-phosphatase type II |
| INPP5D | Inositol polyphosphate-5-phosphatase D |
| INPP5J | Inositol polyphosphate-5-phosphatase J |
| INPPL1 | Inositol polyphosphate phosphatase like 1 |
| IRS | Insulin receptor substrate |
| IRS1 | Insulin receptor substrate protein 1 |
| KLK3 | Kallikrein related peptidase 3 |
| LAT1/2/3 | L-type amino acid transporter 1/2/3 |
| LDHA | L-lactate dehydrogenase A chain |
| LEF | Lymphoid enhancer binding factor |
| LH | Luteinizing hormone |
| LHRH | Luteinizing hormone-releasing hormone |
| LKB1 | Liver kinase B1 |
| LRP5/6 | Low-density lipoprotein receptor-related proteins 5 and 6 |
| MAPK | Mitogen-activated protein kinase |
| MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 |
| mCRPC | Metastatic castrate resistant prostate cancer |
| MDM2 | Mouse double minute 2 homolog |
| MEK | Mitogen-activated protein kinase kinase |
| MSKCC | Memorial Sloan Kettering Cancer Centre |
| mLST8 | MTOR associated protein LST8 homolog |
| MMTV-PyMT | Mouse mammary tumor virus-polyoma middle tumor-antigen |
| MNK1 | MAP kinase interacting serine/threonine kinase 1 |
| MNK2 | MAP kinase interacting serine/threonine kinase 2 |
| mSIN1 | Mitogen-activated protein kinase associated protein 1 (MAPKAP1) |
| mTOR | Mammalian target of rapamycin |
| mTORC1 | Mammalian target of rapamycin complex 1 |
| mTORC1i | mTORC1 inhibitor |
| mTORC2 | Mammalian target of rapamycin complex 2 |
| MuSK | Muscle specific kinase |
| NF-κB | Nuclear factor kappa light chain enhancer of activated B cells |
| NKX3.1 | NK3 Homeobox 1 |
| NSCLC | Non-small-cell lung carcinoma |
| P | Phosphorylation event |
| PDK1 | Phosphoinositide-dependent kinase 1 |
| PGC-1α | Peroxisome proliferator-activated receptor gamma coactivator 1-alpha |
| PHLPP | PH domain leucine-rich repeat protein phosphatase |
| PHLPP1 | PH domain and leucine rich repeat protein phosphatase 1 |
| PHLPP2 | PH domain and leucine rich repeat protein phosphatase 2 |
| PI | Phosphatidylinositol |
| PI3K | Phosphoinositide 3-kinase |
| PI(3)P | Phosphatidylinositol 3-phosphate |
| PI(3,4)P2 | Phosphatidylinositol 3,4-bisphosphate |
| PIN | Prostate intra-epithelial neoplasia |
| PIP2 | Phosphatidylinositol 4,5-bisphosphate |
| PIP3 | Phosphatidylinositol 3,4,5-trisphosphate |
| PIPP | Proline-rich inositol polyphosphate 5-phosphatase |
| PKB | Protein kinase B, AKT |
| PKC | Protein kinase |
| PKCα | Protein kinase C alpha |
| PLC | Phospholipase C |
| PP2A | Protein phosphatase 2A |
| PPP2CA | Protein phosphatase 2 catalytic subunit Alpha |
| PRAS40 | Proline-rich AKT substrate of 40 kDa |
| PROTOR1 | Protein observed with Rictor-1 |
| PROTOR2 | Protein observed with Rictor-2 |
| PSA | Prostate specific antigen |
| PTEN | Phosphatase and tensin homologue deleted on chromosome 10 |
| PTK7 | Protein tyrosine kinase 7 |
| RAF | Rapidly accelerated fibrosarcoma |
| RAG | Recombination activating genes |
| RAPTOR | Regulatory-associated protein of mTOR |
| RBD | Ras-binding domain |
| RHEB | Ras homolog enriched in brain |
| RICTOR | Rapamycin-insensitive companion of mTOR |
| ROR1/2 | Receptor tyrosine kinase–like orphan receptor-1 and -2 |
| RPS6 | Ribosomal protein S6 |
| rPFS | Radiographic progression-free survival |
| RSK | 90 kDa Ribosomal S6 kinase |
| RTK | Tyrosine kinase receptor |
| RYK | Receptor-like tyrosine kinase |
| S6K | Ribosomal protein S6 kinase/p70 ribosomal S6 kinase |
| SESN1 | Sestrin 1 |
| SGK1 | Serum and glucocorticoid regulated kinase 1 |
| SGK2 | Serum and glucocorticoid regulated kinase 2 |
| SGK3 | Serum and glucocorticoid regulated kinase 3 |
| SH2 | Src homology 2 |
| SHIP1 | SH2 domain-containing inositol 5′-phosphatase 1 |
| SHIP2 | SH2 domain-containing inositol 5′-Phosphatase 2 |
| SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 |
| SLC43A1 | Solute carrier family 43 member 1 |
| SOS | Son of Sevenless |
| SPOP | Speckle type BTB/POZ protein |
| SRC-3 | Steroid receptor co-activator 3 |
| SRF | Serum response factor |
| SU2C-PCF IDT | Stand Up To Cancer & Prostate Cancer Foundation International Dream Team |
| T | Testosterone |
| TAK1 | TGFβ-activated kinase 1 |
| TAZ | Transcriptional coactivator with PDZ binding motif |
| TBC1D7 | TBC1 Domain Family Member 7 |
| TCF | T cell Factor |
| TCGA | The Cancer Genome Atlas |
| TEAD | Transcriptional enhanced associate domain |
| TEL2 | Telomere length regulation protein |
| TGF | Transforming growth factor |
| TMPRSS2-ERG | Transmembrane protease, serine 2: ETS Transcription Factor fusion |
| TRAMP | Transgenic adenocarcinoma mouse prostate |
| TSC1 | Tuberous Sclerosis complex 1 |
| TSC2 | Tuberous Sclerosis complex 2 |
| TTI1 | TELO2 interacting protein 1 |
| Ub | Ubiquitination event |
| ULK1 | Unc-51 Like Autophagy Activating Kinase 1 |
| UVRAG | UV radiation resistance-associated gene; v-ATPase, Vacuolar (H+)-ATPase |
| VPS15 | Vacuolar protein sorting 15 |
| V-ATPase | Vacuolar H+-ATPase |
| WNT | WNT ligand |
| YAP | Yes-associated protein |